Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone

BACKGROUND: Hormone-refractory breast cancer metastatic to bone is a clinically challenging disease associated with high morbidity, poor prognosis, and impaired quality of life owing to pain and skeletal-related events. In a preclinical study using a mouse model of breast cancer and bone metastases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Takalkar, Amol, Adams, Scott, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168986/
https://www.ncbi.nlm.nih.gov/pubmed/25243101
http://dx.doi.org/10.1186/2162-3619-3-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168986/
https://www.ncbi.nlm.nih.gov/pubmed/25243101
http://dx.doi.org/10.1186/2162-3619-3-23

Ejemplares similares